Testimonials Do Not Convert Patients from Brand to Generic Medication

John  Beshears; James J. Choi; David  Laibson; Brigitte C. Madrian; Gwendolyn  Reynolds

Article | American Journal of Managed Care | September 2013

Testimonials Do Not Convert Patients from Brand to Generic Medication

by John Beshears, James J. Choi, David Laibson, Brigitte C. Madrian and Gwendolyn Reynolds

Abstract

Objectives: To assess whether the addition of a peer testimonial to an informational mailing increases conversion rates from brand name prescription medications to lower-cost therapeutic equivalents, and whether the testimonial's efficacy increases when information is added about an affiliation the quoted individual shares with the recipient.

Research Design and Methods: A total of 5,498 union members were randomly assigned to receive 1 of 3 different informational letters: 1 without a testimonial (No Testimonial Group), 1 with a testimonial from a person whose shared union affiliation with the recipient was not disclosed (Unaffiliated Testimonial Group), and 1 with a testimonial from a person whose shared union affiliation with the recipient was disclosed (Affiliated Testimonial Group).

Results: The conversion rate for the No Testimonial Group was 12.2%, which is higher than the Unaffiliated Testimonial Group rate of 11.3% and the Affiliated Testimonial Group rate of 11.7%. The differences between the groups are not statistically significant.

Conclusions: Short peer testimonials do not increase the impact of a mailed communication on conversion rates to lower-cost, therapeutically equivalent medications, even when the testimonial is presented as coming from a more socially proximate peer.

Keywords: testimonial; peer information; social proximity; communication; generic medication; Familiarity; Marketing Communications; Decision Choices and Conditions; Identity; Health Care and Treatment; Marketing Reference Programs; Power and Influence; Brands and Branding; Health Industry;

Format: Print

Read Now

Citation:

Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn Reynolds. "Testimonials Do Not Convert Patients from Brand to Generic Medication." American Journal of Managed Care 19, no. 9 (September 2013): e314–e316.

Founded in 2010, CredEx has been a fast and constant innovator in the microfinance industry in China. Tang Xia, CEO and co-founder of CredEx, has led the company through a number of profound business model innovations in response to external environment changes, which transformed the company from an offline, operation heavy micro lending company to an online, data driven FinTech company. This case describes CredEx’s business model transformation process since its founding and explores the drivers and challenges in different stages of business model innovation and transformation. Ultimately, the case highlights the key capabilities needed to digitize a traditional finance business as well as the organizational changes needed to enable the digitization.

In 2018, Magrabi was the leading retailer of eyeglasses, sunglasses, and other optical products in the Middle East, and it was embarking on a major shift in strategy, transitioning from a brand focused on clinical expertise to a brand that combined technical excellence with a luxury retail experience for customers. This case provides an opportunity to discuss the company’s plans for executing its strategy, especially when it comes to recruiting the right people and setting them up for success.

Faculty & Research

Testimonials Do Not Convert Patients from Brand to Generic Medication

Abstract

Citation:

About the Author

More from the Author